Across TCGA pan-cancer cohorts, DCANP1 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of DCANP1’s most consistent transcriptional readouts.
The strongest signal is observed in lung adenocarcinoma (LUAD), where DCANP1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types DCANP1 is over-expressed in tumor.
LUAD are the cancer types where DCANP1 tumor–normal differential expression is most reproducible.